Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 12 studies | 24% ± 5% | |
| glutamatergic neuron | 4 studies | 41% ± 21% | |
| classical monocyte | 3 studies | 27% ± 4% | |
| macrophage | 3 studies | 18% ± 2% | |
| GABAergic neuron | 3 studies | 39% ± 14% | |
| endothelial cell of vascular tree | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 33% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 98% | 7665.10 | 2601 / 2642 | 99% | 51.72 | 696 / 705 |
| adrenal gland | 100% | 3217.47 | 258 / 258 | 93% | 38.98 | 214 / 230 |
| breast | 97% | 2900.44 | 447 / 459 | 84% | 13.33 | 943 / 1118 |
| lung | 90% | 1875.34 | 518 / 578 | 78% | 8.06 | 897 / 1155 |
| thymus | 82% | 1603.01 | 536 / 653 | 81% | 8.53 | 490 / 605 |
| uterus | 96% | 1983.84 | 163 / 170 | 64% | 9.45 | 296 / 459 |
| bladder | 81% | 1712.76 | 17 / 21 | 73% | 7.84 | 370 / 504 |
| esophagus | 65% | 970.90 | 940 / 1445 | 87% | 10.15 | 160 / 183 |
| kidney | 72% | 1273.18 | 64 / 89 | 78% | 19.11 | 702 / 901 |
| intestine | 73% | 1010.07 | 702 / 966 | 75% | 7.76 | 393 / 527 |
| prostate | 76% | 1189.65 | 186 / 245 | 61% | 4.64 | 305 / 502 |
| stomach | 54% | 693.87 | 194 / 359 | 79% | 10.46 | 225 / 286 |
| skin | 34% | 373.80 | 622 / 1809 | 88% | 23.92 | 416 / 472 |
| pancreas | 19% | 175.38 | 61 / 328 | 97% | 17.67 | 172 / 178 |
| spleen | 100% | 5741.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 3754.87 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 85% | 1505.34 | 736 / 861 | 0% | 0 | 0 / 0 |
| ovary | 31% | 362.09 | 56 / 180 | 50% | 3.84 | 215 / 430 |
| liver | 12% | 121.77 | 27 / 226 | 68% | 5.73 | 278 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 10.51 | 21 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 71% | 6.55 | 32 / 45 |
| blood vessel | 46% | 720.56 | 618 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 39% | 3.20 | 31 / 80 |
| peripheral blood | 36% | 607.70 | 331 / 929 | 0% | 0 | 0 / 0 |
| muscle | 31% | 345.07 | 252 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
| GO_0021766 | Biological process | hippocampus development |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0001755 | Biological process | neural crest cell migration |
| GO_0007411 | Biological process | axon guidance |
| GO_0050919 | Biological process | negative chemotaxis |
| GO_0007417 | Biological process | central nervous system development |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0045499 | Molecular function | chemorepellent activity |
| GO_0030215 | Molecular function | semaphorin receptor binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SEMA6B |
| Protein name | Semaphorin 6B isoform 2 Semaphorin 6B Semaphorin-6B (Semaphorin-Z) (Sema Z) |
| Synonyms | SEMAN UNQ1907/PRO4353 SEMAZ |
| Description | FUNCTION: Functions as a cell surface repellent for mossy fibers of developing neurons in the hippocampus where it plays a role in axon guidance. May function through the PLXNA4 receptor expressed by mossy cell axons. .; FUNCTION: (Microbial infection) Acts as a receptor for P.sordellii toxin TcsL in the in the vascular endothelium. . |
| Accessions | ENST00000586582.6 [Q9H3T3-1] ENST00000586965.1 [Q9H3T3-3] ENST00000677828.1 Q9BXR8 Q9H3T3 A0A7I2V374 ENST00000676793.1 [Q9H3T3-1] |
